previous
report
proteom
fingerprint
present
sera
patient
sever
acut
respiratori
syndrom
sar
could
separ
patient
subgroup
differ
prognos
present
studi
examin
prognost
valu
sarsassoci
proteom
featur
biostatist
analysi
deciph
ident
prognost
valu
data
sarsassoci
serum
proteom
featur
ten
serolog
variabl
sar
adult
patient
treatment
subject
multivari
logist
regress
proteom
featur
mz
mz
mz
mz
identifi
independ
prognost
marker
purif
cationexchang
chromatographi
gel
electrophoresi
proteom
featur
mz
mz
found
platelet
factor
betathromboglobulin
betatg
tandem
mass
spectrometri
respect
associ
decreas
serum
increas
serum
betatg
level
poor
prognosi
confirm
western
blot
previou
studi
suggest
betatg
involv
pathogenesi
acut
respiratori
distress
syndrom
ard
neg
posit
way
respect
result
suggest
betatg
may
also
play
similar
role
develop
ard
sar
patient
abbrevi
ard
acut
respiratori
distress
syndrom
betatg
betathromboglobulin
platelet
factor
sar
sever
acut
respiratori
syndrom
seldi
surfaceenhanc
laser
desorptionion
author
contribut
equal
studi
sever
acut
respiratori
syndrom
sar
caus
human
sar
coronaviru
sarscov
diseas
affect
countri
region
outbreak
diseas
infect
peopl
kill
peopl
patient
requir
highflow
oxygen
therapi
requir
intens
care
unit
icu
admiss
develop
acut
respiratori
distress
syndrom
ard
ardsassoci
caus
account
death
sar
patient
icu
high
percentag
patient
requir
special
treatmentintens
care
high
burden
medic
system
prognost
indicatorsmark
import
risk
stratif
guidanc
treatment
decis
seldi
surfaceenhanc
laser
desorptionion
proteinchip
technolog
use
tool
identifi
diseaseassoci
proteom
fingerprint
plasmaserum
sampl
previous
use
studi
design
avoid
system
bia
found
specif
proteom
fingerprint
compos
proteom
featur
present
sera
adult
sar
patient
fingerprint
could
differenti
sar
case
nonsar
case
similar
clinic
featur
also
separ
patient
subgroup
differ
prognos
result
suggest
sarsassoci
proteom
featur
potenti
prognost
marker
studi
examin
prognost
valu
individu
sarsassoci
proteom
featur
biostatist
analysi
deciph
ident
prognost
valu
platelet
factor
betathromboglobulin
betatg
discov
potenti
marker
poor
prognosi
two
cxc
chemokin
may
play
import
role
develop
ard
sar
patient
patient
inform
proteom
dataset
previou
studi
serum
fingerprint
adult
sar
patient
use
studi
sar
group
includ
male
femal
mean
age
year
rang
year
nonsar
group
includ
male
femal
mean
age
year
rang
year
pretreat
serum
sampl
sar
nonsar
group
repres
first
time
point
hospit
day
onset
fever
sar
case
posit
antisarscov
igg
antibodi
serolog
test
control
group
nonsar
patient
similar
symptom
sar
patient
admit
hospit
sar
patient
later
shown
neg
antisarscov
antibodi
serolog
test
least
week
onset
symptom
serum
proteom
profil
data
obtain
use
seldi
proteinchip
technolog
ciphergen
biosystem
fremont
ca
usa
briefli
serum
sampl
diseas
control
group
random
blind
investig
proteinchip
array
ciphergen
biosystem
use
two
bind
condit
use
one
perform
ph
one
perform
ph
bind
condit
sampl
analyz
duplic
detail
procedur
pleas
refer
previou
public
order
avoid
system
bia
proteom
featur
defin
sarsassoci
meet
two
criteria
normal
peak
intens
significantli
higherlow
sar
patient
compar
nonsar
subject
ii
normal
peak
intens
correl
two
clinicalbiochem
paramet
indic
biolog
meaning
common
proteom
featur
identifi
compar
sar
nonsar
patient
group
twenti
differenti
proteom
featur
found
significantli
correl
two
clinicalbiochem
paramet
result
potenti
biomark
detect
sar
fifteen
five
higher
lower
level
sar
patient
respect
hierarch
cluster
analysi
show
biomark
contain
inform
identifi
sar
patient
high
accuraci
sensit
specif
separ
sar
patient
subgroup
variou
prognosi
patient
requir
icu
care
andor
supplement
oxygen
later
treatment
significantli
enrich
two
cluster
p
among
studi
sar
patient
inform
supplement
oxygen
administr
avail
case
therefor
patient
inform
proteom
dataset
case
use
studi
serum
sampl
employ
studi
use
identif
sarsassoci
proteom
featur
sampl
repres
firsttim
point
hospit
medic
like
steroid
ribavirin
tradit
chines
medicin
intraven
immunoglobulin
given
patient
sampl
collect
sampl
store
aliquot
seldi
proteinchip
profil
protein
purif
western
blot
perform
data
sarsassoci
proteom
featur
ten
serolog
variabl
alt
ldh
bilirubin
total
protein
albumin
globulin
creactiv
peptid
total
white
blood
cell
lymphocyt
count
neutrophil
count
sar
patient
treatment
subject
forward
stepwis
multipl
logist
regress
spss
ibm
predict
icu
admiss
andor
supplement
oxygen
administr
later
period
forward
stepwis
multipl
logist
regress
multivari
analysi
tool
identifi
variabl
independ
prognost
valu
variabl
complet
overlap
prognost
valu
would
give
insignific
pvalu
normal
peak
intens
proteom
featur
transform
subject
multipl
logist
regress
prognost
proteom
featur
purifi
weak
cationexchang
chromatographi
previous
describ
function
group
chromatograph
materi
bind
wash
condit
ident
use
seldi
proteinchip
profil
ceram
bead
biosepra
ciphergen
weak
anion
function
group
proteinchip
array
use
experi
briefli
pool
serum
sampl
first
denatur
buffer
dilut
sampl
bind
buffer
respect
incub
subsequ
wash
bound
protein
elut
ceram
bead
nacl
solut
ziptip
use
desalt
elut
protein
accord
manufactur
instruct
millipor
bedford
usa
desalt
protein
prepar
spot
goldcoat
proteinchip
array
examin
proteinchip
reader
confirm
purifi
protein
mass
target
seldi
proteom
featur
confirm
purifi
protein
resolv
absenc
reduc
chemic
isol
spot
appar
molecul
weight
correspond
seldi
proteom
featur
ii
spot
intens
show
differenti
pattern
serum
sampl
collect
nonsar
patient
sar
patient
differ
prognos
previous
describ
immobil
ph
gradient
ipg
strip
nl
biorad
laboratori
hercul
ca
usa
rehydr
sampl
overnight
first
dimens
ief
separ
run
condit
follow
v
min
v
min
v
min
v
min
final
v
min
second
dimens
sdspage
perform
bristri
polyacrylamid
gel
biorad
laboratori
protein
separ
v
min
ice
bath
protein
gel
visual
either
colloid
blue
invitrogen
san
diego
ca
usa
silver
stain
ge
healthcar
piscataway
nj
usa
gel
imag
digit
densitomet
analyz
pdquest
gel
analysi
softwar
version
biorad
protein
spot
appar
molecular
weight
match
prognost
proteom
featur
excis
subject
mass
spectrometri
ms
analysi
ident
protein
gel
spot
obtain
tandem
mass
spectromet
previous
describ
briefli
gel
piec
destain
reduc
dtt
alkyl
mm
iodoacetamid
iaa
digest
overnight
modifi
porcin
trypsin
sequenc
grade
promega
madison
wi
tryptic
digest
harvest
clean
ziptip
millipor
clean
tryptic
peptid
subject
tandem
ms
analysi
use
abi
malditoftof
system
appli
biosystem
carlsbad
ca
usa
cinnam
acid
matrix
msm
spectra
process
data
explor
softwar
appli
biosystem
version
spectra
subject
gaussian
smooth
filter
width
point
baselin
correct
default
set
peak
detect
use
signal
nois
threshold
fragment
mass
intens
msm
mass
spectrum
subject
onlin
mascot
msm
ion
search
http
wwwmatrixsciencecom
obtain
protein
ident
search
paramet
one
miss
cleavag
trypsin
digest
allow
partial
oxid
methionin
phosphoryl
serinethreoninetyrosin
iodoacetamid
modif
cystein
residu
select
error
toler
valu
parent
peptid
msm
ion
mass
da
respect
protein
identif
result
consid
signific
msm
ion
profil
match
known
protein
ncbinr
databas
pvalu
identifi
protein
access
number
uniprot
protein
databas
report
avail
ensur
unbias
comparison
among
patient
sampl
fix
volum
individu
serum
sampl
load
sdsgel
furthermor
sampl
comparison
eg
sar
case
versu
nonsar
case
separ
sdsgel
transfer
membran
subject
immunoblot
singl
experi
serum
sampl
l
first
denatur
addit
ul
buffer
moll
urea
gl
chap
mmoll
trishcl
ph
incub
ice
min
two
microlit
denatur
serum
sampl
equival
l
neat
serum
denatur
reduc
boil
reduc
sd
sampl
load
buffer
separ
precast
sdspolyacrylamid
gel
biorad
sampl
transfer
pvdf
membran
electroblot
biorad
membran
block
bsa
incub
overnight
gml
rabbit
polyclon
antihuman
platelet
antibodi
abcam
uk
gml
rabbit
polyclon
antihuman
betatg
antibodi
also
call
antihuman
antibodi
abcam
uk
afterward
membran
wash
incub
horseradish
peroxidas
conjug
goat
antirabbit
polyclon
antibodi
dako
denmark
dilut
detect
perform
use
ecl
plu
western
blot
detect
solut
ge
healthcar
signal
visual
chemiluminesc
film
ge
healthcar
result
final
digit
densitomet
analyz
quantiti
one
gel
analysi
softwar
version
biorad
among
sarsassoci
proteom
featur
ten
serolog
variabl
alt
ldh
bilirubin
total
protein
albumin
globulin
creactiv
peptid
total
white
blood
cell
lymphocyt
count
neutrophil
count
multipl
logist
regress
analys
identifi
four
proteom
featur
mz
mz
mz
mz
statist
signific
prognost
marker
supplement
oxygen
administr
icu
admiss
later
period
howev
none
serolog
variabl
statist
signific
peak
intens
mz
mz
proteom
featur
neg
associ
supplement
oxygen
administr
wherea
peak
intens
mz
mz
proteom
featur
posit
associ
supplement
oxygen
administr
icu
admiss
respect
tabl
summar
odd
ratio
pvalu
prognost
proteom
featur
figur
show
gel
view
repres
seldi
mass
spectra
two
prognost
odd
ratio
doubl
normal
peak
intens
pvalu
determin
multipl
logist
regress
forward
stepwis
proteom
featur
sar
patient
without
advers
outcom
attempt
made
purifi
identifi
four
prognost
proteom
featur
support
inform
fig
tandem
ms
success
uncov
ident
protein
spot
appar
molecular
weight
correspond
mz
mz
platelet
betatg
respect
fig
raw
mass
spectrometr
data
provid
support
inform
data
file
confirm
differenti
pattern
ident
mz
mz
proteom
featur
serum
sampl
subject
western
blot
analysi
use
specif
antibodi
betatg
betatg
antibodi
also
detect
precursor
protein
betatg
connect
tissueactiv
peptid
iii
ctapiii
appear
weak
upper
band
western
blot
fig
agreement
proteom
profil
data
serum
level
betatg
level
sar
patient
significantli
lower
higher
nonsar
patient
respect
fig
support
inform
fig
b
compar
sar
patient
without
supplement
oxygen
administr
later
period
serum
level
betatg
level
significantli
lower
higher
patient
supplement
oxygen
administr
respect
fig
support
inform
fig
emerg
sar
stimul
research
innat
immun
respons
coronavirus
sar
recur
sinc
first
outbreak
research
studi
pathogenesi
sar
base
use
anim
cell
line
model
one
major
reason
lead
limit
knowledg
sar
pathogenesi
coronaviru
caus
inflamm
damag
lung
sever
case
ard
occur
acut
phase
sar
coronaviru
sarscov
infect
wherea
diffus
alveolar
damag
occur
organ
phase
consid
clinic
devast
endstag
lung
diseas
variou
studi
indic
sarscov
escap
induct
antivir
type
interferon
tissu
cell
chemokin
strongli
upregul
infect
cell
best
knowledg
first
studi
demonstr
prognost
valu
serum
betatg
predict
need
supplement
oxygen
sar
patient
betatg
cxc
chemokin
involv
modul
immun
respons
result
studi
also
provid
novel
insight
pathogenesi
sar
also
call
produc
secret
variou
cell
type
although
previous
believ
exclus
produc
platelet
megakaryocyt
biolog
function
fulli
understood
shown
particip
variou
function
immun
system
promot
interact
neutrophil
endotheli
cell
inhibit
tcell
prolifer
etc
betatg
first
protein
betatg
famili
describ
member
betatg
famili
cxc
chemokin
compris
pbp
ctapiii
betatg
encod
gene
ppbp
variat
number
ntermin
amino
acid
ctapiii
consid
precursor
betatg
function
role
betatg
complet
elucid
evid
shown
member
betatg
famili
differ
abil
neutrophil
chemoattract
stimul
neutrophil
adhes
transendotheli
migrat
neutrophil
also
call
key
potent
member
respons
recruit
activ
neutrophil
although
play
import
role
neutrophil
activ
inflammatori
reaction
act
differ
molecular
pathway
function
relationship
among
betatg
highli
complex
one
hand
betatg
famili
member
diverg
role
neutrophil
regul
inhibit
product
precursor
ctapiii
stimul
unstimul
neutrophil
mast
cell
hand
induc
human
natur
killer
cell
synthes
releas
sar
patient
develop
ard
ard
regard
sever
stage
acut
lung
injuri
inflammatori
mediat
play
import
role
pathogenesi
ard
recruit
activ
neutrophil
high
level
betatg
found
bronchoalveolar
lavag
fluid
patient
ard
lower
level
also
observ
bronchoalveolar
lavag
fluid
ard
patient
although
differ
statist
signific
view
find
previou
current
studi
postul
increas
betatg
decreas
level
may
play
import
role
develop
ard
sar
patient
betatg
repeatedli
report
biomark
variou
patholog
condit
increas
level
plasma
usual
associ
increas
betatf
convent
elev
plasma
level
plasma
betatg
use
indic
platelet
activ
increas
plasma
level
betatg
propos
use
diagnosticprognost
biomark
variou
kind
diseas
diagnosi
megakaryoblast
leukemia
predict
thrombot
complic
patient
artifici
heart
valv
prognosi
cerebr
infarct
etc
moreov
uncommon
plasmaserum
proteom
profil
identifi
altern
plasmaserum
level
either
betatf
level
potenti
diagnosticprognost
biomark
exampl
elev
associ
poor
respons
infliximab
rheumatoid
arthriti
decreas
level
associ
acut
lymphoblast
leukemia
wherea
decreas
betatg
level
observ
patient
pancreat
cancer
parallel
observ
decreas
level
increas
betatg
level
blood
report
present
studi
sar
ard
similar
dysregul
pattern
observ
bronchoalveolar
lavag
fluid
therefor
like
combin
decreas
level
increas
betatg
level
blood
specif
indic
poor
prognosi
sar
conclus
four
proteom
featur
found
potenti
prognost
marker
sar
biostatist
analysi
two
identifi
cxc
chemokin
betatg
decreas
increas
betatg
pretreat
serum
sampl
associ
need
supplement
oxygen
later
treatment
period
previou
studi
suggest
betatg
may
involv
pathogenesi
ard
neg
posit
way
respect
result
henc
suggest
betatg
may
also
play
import
role
develop
ard
sar
patient
